New documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease
New documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease 10 November 2023 – A…
Pharmaceuticals, Biotechnology and Life Sciences
New documentary highlights pioneering scientific research into new targets for treatment of motor neuron disease 10 November 2023 – A…
MIAMI, Nov. 09, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused…
RESEARCH TRIANGLE PARK, N.C., Nov. 09, 2023 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty…
NEW HOPE, Pa., Nov. 09, 2023 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”),…
SALT LAKE CITY, Nov. 08, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN) (the “Company” or “Myriad Genetics”), a…
— FRUZAQLA is the first targeted therapy approved in the U.S. for metastatic colorectal cancer regardless of biomarker status or prior…
Company reported positive clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study Positive benefits…
TPST-1120 demonstrates superiority compared to standard of care across multiple study endpoints in randomized first-line HCC studyNew capital strengthens balance…
BERWYN, Pa., Nov. 08, 2023 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS), a late-stage clinical drug platform company developing…
CALGARY, Alberta, Nov. 08, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX…